Eikonizo Therapeutics, Inc. — Form D
Eikonizo Therapeutics, Inc. of BEVERLY, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-04-17. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2018-04-17
- Form: D
- Accession: 0001735756-18-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $2.0M
- Investors: 2
- Date of first sale: 2018-03-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-310400
Issuer
- Name: Eikonizo Therapeutics, Inc.
- CIK: 0001735756
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 996 HALE STREET, BEVERLY, MA, 01915
- Phone: 617-308-4405
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| William Shaw | Director | Grand Cayman, E9 |
| William Shaw | Executive Officer | Grand Cayman, E9 |
| Stacie Weninger | Director | Watertown, MA |
| Janice Kranz | Director | Beverly, MA |
| Janice Kranz | Executive Officer | Beverly, MA |
| Kevin Kinsella | Director | Beverly, MA |
Other filings by this issuer (1)
More